|
 Company: Sanofi-Aventis SA, Istanbul, Turkey
Company Description: Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: S
Nomination Category: Live Event Awards Categories
Nomination Sub Category: Best Corporate Image Event
Nomination Title: Sanofi-Aventis Entry: AkademiKA Awards
1. The date on which this nominated production was first presented:
February, 2009
2. Briefly describe the nominated event's communications objectives and how it met those objectives (up to 500 words). After this description, provide URLs to online photographs, video clips, press clippings, etc. that will portray the event for the judges. IMPORTANT: Begin each link with http://, and enclose each link in square brackets; for example, [http://www.youraddress.com]:
What better result can an event have than to focus on community issues that
align with its business objectives? Sanofi-aventis (S-A) did just that: it
created an awards program to top off the launch of AkademiKa – a one of a kind
training program in clinical research and development (R&D) for doctors in
Turkey and beyond...and furthered its goal to perpetuate its corporate image as
a leading global R&D pharmaceutical company.
Turkey is a major medical market for French pharmaceutical giant Sanofi-Aventis
(S-A), yet the competition in the sector is daunting. While conducting market
research to gain insights into the Turkish market, Sanofi-aventis Turkey
discovered an unmet need: standardized training in clinical research. Simply
put, there was no activity in drug research and development in Turkey. It would
be difficult to grow and to be competitive without this dimension to their business.
S-A set out to create a massive training program topped off by a stunning awards
event.
The communication objectives of S-A’s awards program was to reward and motivate
clinical researchers and institutions for their successes in clinical R&D – and
to create awareness amongst the sector, the general public, and the Turkish
government of S-A as a leader in drug development. Ultimately, the event was a
fresh approach to stamping S-A’s image with its constituencies.
Never before had such an event taken place in any country in the world where S-A
operated. And never has such positive excitement been created in the Turkish
pharma sector. The event literally put Turkey on the map in drug development.
Awards were given for innovation and best practices in clinical research. The
judges reviewed the clinical research submissions from 22 teams from academia,
hospitals and companies. They were scored according to publishability,
realization of the first patients to participate in clinical research trials,
attendance at educational activities during the training program, and many other
factors.
The event itself was a grand affair, particularly for this sector and was
attended by nearly 200 people. Multi media was used to present clips of the
training, the winners’ activities, statements by leading figures, images from
around the world. There was simulcast coverage online and live input from
clinicians around Turkey. Print materials solidified the theme of establishing
S-A as the leader in clinical R&D in drug development. S-A Turkey’s Country
Manager, Olivier Guillaume was the colorful
master of ceremony and awards were given by S-A Medical Director Edibe Taylan.
Three top awards were given, plus two runner up winners.
Media coverage was especially enthusiastic, with attendance and coverage by the
top major Turkish business and medical media, resulting in 33 articles and
interviews, reaching more than 1.7 million readers.
As a result of this event, a Turkish university (Ege), who won an award, made a
major investment to improve its laboratories, clinics and technical
infrastructure having been motivated to be the center of drug research and
development in its region. Now, Ege is one of Europe’s most celebrated
universities in the field.
AkademiKa® Awards has been singled out by the Turkish health authorities and
academicians for its role in stimulating best practices in clinical drug
research and development. With its presence in Turkey, the AkademiKA® Awards
event spurs the intellectual evolution of the country. In terms of industry and
science – in a multitude of sectors - it helps to elevate the country’s business
practices to international standards …thus increasing Turkey’s overall credibility.
Due to the success in Turkey, in 2010, the AkademiKA® Awards event is being
delivered in Dubai in the name of AkademiKA®International.
http://thestevies.com/IBA10Attachments/Sanofi-Aventis/AkademiKAMediaClips.pptx
http://thestevies.com/IBA10Attachments/Sanofi-Aventis/SanofiBrochure.pdf
http://thestevies.com/IBA10Attachments/SanofiPoster.pdf
3. List the appropriate creative and production credits for this entry: Advertising Agency/City: Client: Art Director: Cinematographer: Creative Director: Designer: Director: Illustrator/City: Music Producer/City: Photographer/City: Printer/City: Producer: Production Company/City: Programmer: Writer: Web Development Firm/City:
Advertising Agency/City: Futureland Marketing Communications, Istanbul
Client: Sanofi-aventis Group, Turkey
Art Director: Sibel Cebeci, Evren Karadenizli
Creative Director: Ilker Çaglayan
Designer: Sibel Cebeci
Director: Hanzade Tulan
Photographer/City: Ersin Ergin, Istanbul
Printer/City: Scala Printing House, Istanbul
Production Company/City: OI OI Productions, Istanbul
Writer: Baris Evren Erdogan
|
